These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 34894107)

  • 1. MutT Homolog 1 Inhibitor Karonudib Attenuates Autoimmune Hepatitis by Inhibiting DNA Repair in Activated T Cells.
    Chen Y; Hua X; Huang B; Karsten S; You Z; Li B; Li Y; Li Y; Liang J; Zhang J; Wei Y; Chen R; Lyu Z; Xiao X; Lian M; Wei J; Fang J; Miao Q; Wang Q; Berglung UW; Tang R; Helleday T; Ma X
    Hepatol Commun; 2022 May; 6(5):1016-1031. PubMed ID: 34894107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MTH1 as a target to alleviate T cell driven diseases by selective suppression of activated T cells.
    Karsten S; Fiskesund R; Zhang XM; Marttila P; Sanjiv K; Pham T; Rasti A; Bräutigam L; Almlöf I; Marcusson-Ståhl M; Sandman C; Platzack B; Harris RA; Kalderén C; Cederbrant K; Helleday T; Warpman Berglund U
    Cell Death Differ; 2022 Jan; 29(1):246-261. PubMed ID: 34453118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptation to Chronic-Cycling Hypoxia Renders Cancer Cells Resistant to MTH1-Inhibitor Treatment Which Can Be Counteracted by Glutathione Depletion.
    Hansel C; Hlouschek J; Xiang K; Melnikova M; Thomale J; Helleday T; Jendrossek V; Matschke J
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karonudib has potent anti-tumor effects in preclinical models of B-cell lymphoma.
    Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Øy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Våtsveen TK
    Sci Rep; 2021 Mar; 11(1):6317. PubMed ID: 33737576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MutT Homolog 1 (MTH1) maintains multiple KRAS-driven pro-malignant pathways.
    Patel A; Burton DG; Halvorsen K; Balkan W; Reiner T; Perez-Stable C; Cohen A; Munoz A; Giribaldi MG; Singh S; Robbins DJ; Nguyen DM; Rai P
    Oncogene; 2015 May; 34(20):2586-96. PubMed ID: 25023700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High iodine induces DNA damage in autoimmune thyroiditis partially by inhibiting the DNA repair protein MTH1.
    Li F; Wu Y; Chen L; Hu L; Zhu F; He Q
    Cell Immunol; 2019 Oct; 344():103948. PubMed ID: 31311621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amygdalin (Vitamin B17) pretreatment attenuates experimentally induced acute autoimmune hepatitis through reduction of CD4+ cell infiltration.
    Elsaed WM
    Ann Anat; 2019 Jul; 224():124-132. PubMed ID: 31100343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OGG1 co-inhibition antagonizes the tumor-inhibitory effects of targeting MTH1.
    Zhang L; Misiara L; Samaranayake GJ; Sharma N; Nguyen DM; Tahara YK; Kool ET; Rai P
    Redox Biol; 2021 Apr; 40():101848. PubMed ID: 33450725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrahepatic activated leukocyte cell adhesion molecule induces CD6
    Qian Q; Cui N; Huang B; Zhao Y; Liu Q; Hu M; Li B; Wang Q; Miao Q; You Z; Ma X; Tang R
    Front Immunol; 2022; 13():967944. PubMed ID: 36159854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPN10466 ameliorates Concanavalin A-induced autoimmune hepatitis in mice via inhibiting ERK/JNK/p38 signaling pathway.
    Liu G; Zhang Y; Han S; Zhuang W; Lv J; Han M; Xie L; Jiang X; Wang C; Saimaier K; Shen J; Du C
    Eur J Immunol; 2023 Apr; 53(4):e2250100. PubMed ID: 36648433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune mechanisms of Concanavalin A model of autoimmune hepatitis.
    Wang HX; Liu M; Weng SY; Li JJ; Xie C; He HL; Guan W; Yuan YS; Gao J
    World J Gastroenterol; 2012 Jan; 18(2):119-25. PubMed ID: 22253517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TPN10475 alleviates concanavalin A-induced autoimmune hepatitis by limiting T cell development and function through inhibition of PI3K-AKT pathway.
    Wang C; Han M; Li X; Lv J; Zhuang W; Xie L; Liu G; Saimaier K; Han S; Shi C; Hua Q; Zhang R; Jiang X; Wang G; Du C
    Int Immunopharmacol; 2023 Dec; 125(Pt A):111110. PubMed ID: 37883813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and development of MTH1 inhibitors for treatment of cancer.
    Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
    Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The therapeutic effects of Yongdamsagan-tang on autoimmune hepatitis models.
    Park J; Kim H; Lee IS; Kim KH; Kim Y; Na YC; Lee JH; Jang HJ
    Biomed Pharmacother; 2017 Oct; 94():244-255. PubMed ID: 28763748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.
    Magkouta SF; Pappas AG; Vaitsi PC; Agioutantis PC; Pateras IS; Moschos CA; Iliopoulou MP; Kosti CN; Loutrari HV; Gorgoulis VG; Kalomenidis IT
    JCI Insight; 2020 Jun; 5(12):. PubMed ID: 32554927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotic MTH1 Inhibitors in Treatment of Cancer.
    Helleday T
    Cancer Treat Res; 2023; 186():223-237. PubMed ID: 37978139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B Virus X Protein Increases 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine (8-Oxodg) Level via Repressing MTH1/ MTH2 Expression in Hepatocytes.
    Lin YT; Liu W; He Y; Wu YL; Chen WN; Lin XJ; Lin X
    Cell Physiol Biochem; 2018; 51(1):80-96. PubMed ID: 30448843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effect of Yiguanjian decoction against DNA damage on concanavalin A-induced liver injury mice model.
    Tian M; Liu W; You H; Zhao Q; Ouyang L; Gao B; Zhang X; Che N
    J Tradit Chin Med; 2016 Aug; 36(4):471-8. PubMed ID: 28459511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of receptor-interacting protein 3 improves experimental autoimmune hepatitis].
    Liu M; Zhang HX; Zhang L; Zhao JW; Zhou L; Wang BM
    Zhonghua Gan Zang Bing Za Zhi; 2022 Nov; 30(11):1231-1236. PubMed ID: 36891703
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg/Th17 cell differentiation.
    Xia G; Wu S; Wang X; Fu M
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1293-1300. PubMed ID: 30290123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.